Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 3
1(33.3%)
3Total
N/A(2)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT00128336Phase 3Completed

The Heat Study: 2 Year Lifestyle Intervention in Overweight Women to Encourage Weight Management

Role: collaborator

NCT00124553Not ApplicableUnknown

LOADD (Lifestyle Over and Above Drugs in Diabetes) Study

Role: lead

NCT00208598Completed

Measures of Obesity and Co-Morbid Conditions in Maori

Role: lead

NCT00208637Not ApplicableCompleted

He Purongo Mo Nga Kai Hei Arai i Te Matehuka - Dietary Diabetes Prevention Study for Maori

Role: lead

All 4 trials loaded